Articles by Juan Berenguer

Similar effectiveness of direct-acting antiviral against hepatitis C virus in patients with and without HIV infection

Montes, María Luisa; Olveira, Antonio; Ahumada, Adriana; More

AIDS. 31(9):1253-1260, June 1st, 2017.

Optimal vitamin D plasma levels are associated with lower bacterial DNA translocation in HIV/hepatitis c virus coinfected patients

García-Álvarez, Mónica; Berenguer, Juan; Jiménez-Sousa, Maria Ángeles; More

AIDS. 30(7):1069-1074, April 24th, 2016.

Impact of patatin-like phospholipase domain-containing 3 gene polymorphism (rs738409) on severity of liver disease in HIV/hepatitis C virus-coinfected patients

Jiménez-Sousa, María A.; Berenguer, Juan; García-Álvarez, Mónica; More

AIDS. 30(3):465-470, January 28th, 2016.

SLC30A8 rs13266634 polymorphism is related to a favorable cardiometabolic lipid profile in HIV/hepatitis C virus-coinfected patients

Pineda-Tenor, Daniel; Micheloud, Dariela; Berenguer, Juan; More

AIDS. 28(9):1325-1332, June 1st, 2014.

HLA-E variants are associated with sustained virological response in HIV/hepatitis C virus-coinfected patients on hepatitis C virus therapy

Guzmán-Fulgencio, María; Berenguer, Juan; Rallón, Norma; More

AIDS. 27(8):1231-1238, May 15th, 2013.

Analysis of IL28B alleles with virologic response patterns and plasma cytokine levels in HIV/HCV-coinfected patients

Fernández-Rodríguez, Amanda; Rallón, Norma; Berenguer, Juan; More

AIDS. 27(2):163-173, January 14th, 2013.

Changes in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravir

Martínez, Esteban; D’Albuquerque, Polyana M.; Llibre, Josep M.; More

AIDS. 26(18):2315-2326, November 28th, 2012.

Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy

Berenguer, Juan; Alejos, Belén; Hernando, Victoria; More

AIDS. 26(17):2241-2246, November 13th, 2012.

Transient elastography to rule out esophageal varices and portal hypertensive gastropathy in HIV-infected individuals with liver cirrhosis

Montes Ramirez, Maria L.; Pascual-Pareja, Jose F.; Sánchez-Conde, Matilde; More

AIDS. 26(14):1807-1812, September 10th, 2012.

Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms

Hernando, Victoria; Sobrino-Vegas, Paz; Burriel, M. Carmen; More

AIDS. 26(14):1829-1834, September 10th, 2012.

European mitochondrial DNA haplogroups and liver fibrosis in HIV and hepatitis C virus coinfected patients

García-Álvarez, Mónica; Guzmán-Fulgencio, María; Berenguer, Juan; More

AIDS. 25(13):1619-1926, August 24th, 2011.

The natural history of liver cirrhosis in HIV–hepatitis C virus-coinfected patients

López-Diéguez, María; Montes, María L; Pascual-Pareja, José F; More

AIDS. 25(7):899-904, April 24th, 2011.

Hepatitis C virus infection is associated with endothelial dysfunction in HIV/hepatitis C virus coinfected patients

de Castro, Isabel Fernández; Micheloud, Dariela; Berenguer, Juan; More

AIDS. 24(13):2059-2067, August 24th, 2010.

Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study

Martinez, Esteban; Larrousse, María; Llibre, Josep M; More

AIDS. 24(11):1697-1707, July 17th, 2010.

Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis

De Luca, Andrea; Ammassari, Adriana; Pezzotti, Patrizio; More

AIDS. 22(14):1759-1767, September 12th, 2008.

Treatment of AIDS-associated progressive multifocal leukoencephalopathy with highly active antiretroviral therapy

Miralles, Pilar; Berenguer, Juan; de Viedma, Darío García; More

AIDS. 12(18):2467-2472, December 24th, 1998.